Asia Deal Watch: India’s Encube Targeted As Private Equity Interest In CDMOs Grows

Plus deals involving Y-Biologics/Pierre Fabre, Contera/Abzu, Chugai/Alebund, Catalyst/DyDo, Spergogenix/Abbiska, Nippon Gene/ERS Genomics, Simcere/Vivoryon, Dr. Reddy’s/Journey Medical and Innovent/Synaffix.

Asia Deal Watch
• Source: Alamy

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.

Private equity interest in the contract development and manufacturing space continues to build, with Quadria Capital and its co-investors, including Gulf Islamic Investments, now buying into India’s Encube

More from Deals

More from Business